Bicycle Therapeutics plc
NASDAQ:BCYC · NASDAQ Global Select
-$0.06 today
Vol 0.32M · Avg 0.49M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-44.67%
Period High
$8.87
Period Low
$4.00
Latest
$4.00
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
$1.44B
RAPT Therapeutics, Inc.
RAPT
$959.26M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$888.39M
Omeros Corporation
NASDAQ:OMER
$746.91M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$501.33M
Prothena Corporation plc
NASDAQ:PRTA
$463.33M
Compass Therapeutics, Inc.
NASDAQ:CMPX
$280.71M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$268.66M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$194.53M
ADC Therapeutics S.A.
NYSE:ADCT
$137.96M
What is the latest BCYC filing?
The latest filing shown is 8-K dated Jun 18, 2026.
How many recent filings does BCYC have?
Intrinsic Alpha currently shows 20 recent filings for BCYC.
Explore More
Continue the stock analysis
Jump to another research area for this company.